3 completed, 2 unknown, 1 recruiting, 1 terminated. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 3, Unknown 2, Recruiting 1, Terminated 1 |
Follow Speech Disorders: new trials by email Literature Review of Speech Disorders trials Research Report on Speech Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study Between Three Different Methods for Stuttering Therapy in Children speech therapy only, hyperbaric oxygen therapy, medical treatment - Stuttering, Childhood | Phase 4 | Unknown | Sohag University | 30 | 2022-04-01 | 2022-03-22 |
| Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech AV-1451 - PPA, Non-fluent Aphasia | Phase 4 | Recruiting | Mayo Clinic | 50 | 2018-07-01 | 2025-11-12 |
| Memantine and Intensive Speech-Language Therapy in Aphasia memantine, constraint-induced language therapy (CIAT), placebo - Aphasia, Stroke | Phase 4 | Completed | Gabinete Berthier y Martínez | 28 | 2005-03-01 | 2008-03-21 |
| Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled Trial memantine, constraint-induced language therapy - Aphasia, Stroke | Phase 4 | Unknown | Gabinete Berthier y Martínez | 30 | 2005-03-01 | 2005-09-20 |
| Dopaminergic Enhancement of Learning and Memory in Aphasia levodopa - Cerebrovascular Accident, Aphasia | Phase 4 | Completed | University Hospital Muenster | 12 | 2005-01-01 | 2013-10-07 |
| Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial Donepezil - Stroke, Aphasia | Phase 4 | Completed | Gabinete Berthier y Martínez | 30 | 2003-02-01 | 2005-09-20 |
| A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke Piracetam, Placebo - Acute Ischaemic Middle Cerebral Artery Stroke | Phase 4 | Terminated | UCB S.A. - Pharma Sector | 571 | 1998-08-01 | 2013-08-30 |
Aphasia (6) · Stroke (5) · Aphasia, Broca (1) · Aphasia, Primary Progressive (1) · Apraxias (1) · Ischemia (1) · Primary Progressive Nonfluent Aphasia (1) · Stuttering (1)
Communication Disorders (7) · Language Disorders (7) · Nervous System Diseases (7) · Neurobehavioral Manifestations (7) · Neurologic Manifestations (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Brain Diseases (6) · Central Nervous System Diseases (6) · Cardiovascular Diseases (5) · Cerebrovascular Disorders (5) · Vascular Diseases (5) · Dementia (1) · Frontotemporal Lobar Degeneration (1)
Memantine (2) · 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1) · Donepezil (1) · Hyperbaric Oxygenation (1) · Levodopa (1) · Piracetam (1)
Gabinete Berthier y Martínez (3) · Mayo Clinic (1) · Sohag University (1) · UCB S.A. - Pharma Sector (1) · University Hospital Muenster (1)
Spain (4) · Germany (2) · Argentina (1) · Austria (1) · Belgium (1) · France (1) · Greece (1) · Hungary (1) · Italy (1) · Norway (1) · Poland (1) · Singapore (1) · Sweden (1) · Taiwan (1) · Turkey (Türkiye) (1)
Marcelo L. Berthier, M.D., Ph.D (2) · Caterina Breitenstein, PhD (1) · Jennifer Whitwell, PhD (1) · Marcelo L. Berthier, M.D., Ph.D. (1) · Stefan Knecht, MD (1)
R01DC012519 (1)